NEXT Oncology San Antonio
NEXT Oncology San Antonio is a clinical research center focused on early-phase oncology trials, providing access to novel cancer therapies for patients while partnering with pharmaceutical and biotech sponsors to conduct Phase I and other advanced clinical studies. The organization generates revenue through clinical trial contracts and related research services.
- Clinical Trial & Research Software
- Revenue
- $8.0M
- Employees
- 40
- Founded
- 2018
- Headquarters
- San Antonio, United States of America
What 6 Arbolus experts think of NEXT Oncology San Antonio
NPS scores are predominantly high: 33% rated 10, 33% rated 8 or 9, and 33% rated 7, yielding strong overall sentiment. Renewal intent is positive or confirmed among all Influencer roles, with only one Not Sure response (User, less than 1 year). Stickiness is significant: 67% have implemented for over 1 year, 17% less than 1 year, 17% pilot stage. Key themes are high user satisfaction, strong adoption, and loyalty among long-term customers.Overall Customer Sentiment: Positive
Who reviewed NEXT Oncology San Antonio
- C-Suite 83% (5)
- Director 17% (1)
Employer names and spend open once the report publishes.
Tell us when the NEXT Oncology San Antonio report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
33 Net Promoter Score, from 6 scored reviews- Promoters 2
- Passives 4
- Detractors 0
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 67%Plan to renew, by seniority
- 100% 2 answers
- 0% 1 answer
- 9/10 Average score from customers who will renew
- 7/10 Average score from undecided customers
For people who use NEXT Oncology San Antonio
Do you use NEXT Oncology San Antonio at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 6 customers of NEXT Oncology San Antonio have already contributed
Takes a few minutes. Your identity stays anonymous.